Who owns Applied Therapeutics Inc?
- CUSIP Number: 03828a101
Tip: Access positions for across all investors
Analyze quarterly positions in Applied Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Applied Therapeutics stock
Who bought or sold Applied Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| T. Rowe Price Investment Management | 22M | $2.2M | 2% | Dec 2025 |
|
| Vanguard Group | 6.4M | $635k | 25% | Dec 2025 |
|
| Knoll Capital Management | 6.1M | $605k | -22% | Dec 2025 |
|
| Deltec Asset Management | 3.8M | $385k | 100% | Dec 2025 |
|
| BlackRock | 3.3M | $318k | -15% | Dec 2025 |
|
| Renaissance Technologies | 2.7M | $271k | 100% | Dec 2025 |
|
| Pathstone Holdings | 2.6M | $305k | 0% | Dec 2025 |
|
| Adage Capital Partners GP | 2.2M | $1.3M | 83% | Sep 2025 |
|
| Jane Street | 2.1M | $209k | 3289% | Dec 2025 |
|
| Millennium Management | 1.9M | $1.2M | -2% | Sep 2025 |
|
| Geode Capital Management | 1.5M | $149k | 17% | Dec 2025 |
|
| UBS Group | 719k | $72k | -62% | Dec 2025 |
|
| Deutsche Bank Aktiengesellschaft | 622k | $62k | 0% | Dec 2025 |
|
| Graham Capital Management | 573k | $57k | 100% | Dec 2025 |
|
| State Street Corporation | 558k | $56k | 8% | Dec 2025 |
|
| Equitec Proprietary Markets | 553k | $55k | 100% | Dec 2025 |
|
| Virtu Financial | 496k | $50k | 873% | Dec 2025 |
|
| Lynx1 Capital Management | 411k | $41k | 100% | Dec 2025 |
|
| Marshall Wace | 337k | $34k | -87% | Dec 2025 |
|
| Hennion & Walsh Asset Management | 327k | $33k | 16% | Dec 2025 |
|
| Bank of New York Mellon | 254k | $25k | 219% | Dec 2025 |
|
| Citadel Advisors | 252k | $153k | -66% | Sep 2025 |
|
| Northern Trust | 245k | $25k | 41% | Dec 2025 |
|
| Rockefeller Capital Management | 242k | $24k | -38% | Dec 2025 |
|
| Royal Bank of Canada | 203k | $0 | 15241% | Sep 2025 |
|
| Gts Securities | 200k | $20k | 100% | Dec 2025 |
|
| Two Sigma Investments | 199k | $120k | -67% | Sep 2025 |
|
| Change Path | 170k | $17k | 70% | Dec 2025 |
|
| Goldman Sachs Group | 146k | $15k | -6% | Dec 2025 |
|
| AQR Capital Management | 110k | $66k | -62% | Sep 2025 |
|
| Roble, Belko & Company | 66k | $7.0k | 113% | Dec 2025 |
|
| Tudor Investment Corporation | 58k | $35k | 0% | Sep 2025 |
|
| Susquehanna International | 53k | $5.3k | -92% | Dec 2025 |
|
| Wolverine Trading | 51k | $31k | 100% | Sep 2025 |
|
| Sphera Funds Management | 50k | $5.0k | 0% | Dec 2025 |
|
| Group One Trading | 49k | $4.9k | -35% | Dec 2025 |
|
| SG Americas Securities | 42k | $4.0k | 154% | Dec 2025 |
|
| Adams Wealth Management | 39k | $3.9k | 0% | Dec 2025 |
|
| CacheTech | 39k | $3.9k | 0% | Dec 2025 |
|
| Point72 Asia | 33k | $20k | 100% | Sep 2025 |
|
| Diadema Partners | 20k | $2.0k | 6% | Dec 2025 |
|
| Tower Research Capital | 20k | $2.0k | -43% | Dec 2025 |
|
| FMR | 18k | $11k | -2% | Sep 2025 |
|
| Cresset Asset Management | 17k | $1.7k | 0% | Dec 2025 |
|
| Point72 Asset Management | 17k | $1.7k | 100% | Dec 2025 |
|
| Perennial Investment Advisors | 12k | $1.2k | 0% | Dec 2025 |
|
| Jpmorgan Chase & Co | 7.6k | $4.6k | 100% | Sep 2025 |
|
| Quest Partners | 4.7k | $466.100000 | 0% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 3.0k | $297.102600 | -14% | Dec 2025 |
|
| SBI Securities | 788.00 | $79.036400 | -4% | Dec 2025 |
|
| Rhumbline Advisers | 544.00 | $54.019200 | 0% | Dec 2025 |
|
| Optiver Holding B.V. | 427.00 | $42.998900 | 100% | Dec 2025 |
|
| Federation des caisses Desjardins du Quebec | 84.00 | $7.996800 | 0% | Dec 2025 |
|
| Barclays | 1.00 | $0 | -100% | Dec 2025 |
|
Who sold out of Applied Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Vestal Point Capital | Sep 2025 | 14M | $8.6M |
| Propel Bio Management | Sep 2025 | 11M | $6.8M |
| Simplify Asset Management | Sep 2025 | 4.5M | $2.7M |
| Pnc Financial Services | Sep 2025 | 2.9M | $1.8M |
| Rock Springs Capital Management | Sep 2025 | 2.1M | $1.3M |
| Franklin Resources | Sep 2025 | 2.0M | $1.2M |
| Qube Research & Technologies | Sep 2025 | 1.2M | $706k |
| Hudson Bay Capital Management | Sep 2025 | 806k | $487k |
| Two Sigma Advisers | Jun 2025 | 304k | $95k |
| Birchview Capital | Sep 2025 | 225k | $136k |
| Squarepoint Ops | Sep 2025 | 159k | $96k |
| Scientech Research | Sep 2025 | 105k | $64k |
| Hrt Financial | Sep 2025 | 95k | $57k |
| Ethic | Sep 2025 | 27k | $16k |
| China Universal Asset Management | Sep 2025 | 25k | $15k |
| XTX Topco | Sep 2025 | 24k | $14k |
| HPM Partners | Sep 2025 | 17k | $10k |
| JustInvest | Sep 2025 | 16k | $9.8k |
| Stratos Wealth Advisors | Sep 2025 | 11k | $6.4k |
| Beaumont Capital Management | Sep 2025 | 10k | $6.3k |
| Mirae Asset Global Investments | Sep 2025 | 5.6k | $3.4k |
| Capital Advisors | Sep 2025 | 2.4k | $1.0k |
| Sunbelt Securities | Sep 2025 | 1.0k | $605.000000 |
| CWM | Sep 2025 | 376.00 | $0 |
| Parallel Advisors | Sep 2025 | 100.00 | $60.000000 |